| Autor: |
Granito, Mariana, Alvarenga, Livia, Ribeiro, Marcia, Carvalhosa, Priscila, Andrade, Thaysi, Mesquita, Claudio Tinoco, Stockler-Pinto, Milena Barcza, Mafra, Denise, Cardozo, Ludmila FMF |
| Předmět: |
|
| Zdroj: |
Expert Review of Cardiovascular Therapy; Oct2024, Vol. 22 Issue 10, p565-574, 10p |
| Abstrakt: |
Introduction: Nattokinase (NK) is the primary ingredient of natto, a traditional Asian food made from fermented soybean by Bacillus subtilis natto. Studies have shown that natto reduces the risk of cardiovascular disease (CVD) mortality due to its fibrinolytic and antithrombotic properties. A new field of studies also demonstrates that NK can mitigate molecular pathways related to inflammation and oxidative stress and can be considered an adjuvant strategy for use in many non-communicable diseases (NCDs). This paper is a narrative review of the literature. A search was conducted in PubMed and ScienceDirect up to July 2024. Areas covered: This review discusses the possible effects of NK on mitigating the common complications of NCDs, such as inflammation and oxidative stress. In addition, it provides an update on the most addressed areas related to NK's fibrinolytic and antithrombotic activities. Expert opinion: Due to the fibrinolytic and antithrombotic activity of nattokinase, and more recently added to the anti-inflammatory and antioxidant effects, this enzyme can be used as a new adjuvant therapeutic strategy to mitigate inflammation and oxidative stress in NCDs, including CVD. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
